Cargando…

Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines

Transforming growth factor β (TGF-β) exerts a growth inhibitory effect on many cell types through binding to two types of receptors, the type I and II receptors. Resistance to TGF-β due to lack of type II receptor (RII) has been described in some cancer types including small cell lung cancer (SCLC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Hougaard, S, Nørgaard, P, Abrahamsen, N, Moses, H L, Spang-Thomsen, M, Skovgaard Poulsen, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362261/
https://www.ncbi.nlm.nih.gov/pubmed/10098728
http://dx.doi.org/10.1038/sj.bjc.6690161
_version_ 1782153413948080128
author Hougaard, S
Nørgaard, P
Abrahamsen, N
Moses, H L
Spang-Thomsen, M
Skovgaard Poulsen, H
author_facet Hougaard, S
Nørgaard, P
Abrahamsen, N
Moses, H L
Spang-Thomsen, M
Skovgaard Poulsen, H
author_sort Hougaard, S
collection PubMed
description Transforming growth factor β (TGF-β) exerts a growth inhibitory effect on many cell types through binding to two types of receptors, the type I and II receptors. Resistance to TGF-β due to lack of type II receptor (RII) has been described in some cancer types including small cell lung cancer (SCLC). The purpose of this study was to examine the cause of absent RII expression in SCLC cell lines. Northern blot analysis showed that RII RNA expression was very weak in 16 of 21 cell lines. To investigate if the absence of RII transcript was due to mutations, we screened the poly-A tract for mutations, but no mutations were detected. Additional screening for mutations of the RII gene revealed a GG to TT base substitution in one cell line, which did not express RII. This mutation generates a stop codon resulting in predicted synthesis of a truncated RII of 219 amino acids. The nature of the mutation, which has not previously been observed in RII, has been linked to exposure to benzo[a]-pyrene, a component of cigarette smoke. Since RII has been mapped to chromosome 3p22 and nearby loci are often hypermethylated in SCLC, it was examined whether the lack of RII expression was due to hypermethylation. Southern blot analysis of the RII promoter did not show altered methylation patterns. The restriction endonuclease pattern of the RII gene was altered in two SCLC cell lines when digested with Sma 1. However, treatment with 5-aza-2′-deoxycytidine did not induce expression of RII mRNA. Our results indicate that in SCLC lack of RII mRNA is not commonly due to mutations and inactivation of RII transcription was not due to hypermethylation of the RII promoter or gene. Thus, these data show that in most cases of the SCLC cell lines, the RII gene and promoter is intact in spite of absent RII expression. However, the nature of the mutation found could suggest that it was caused by cigarette smoking. © 1999 Cancer Research Campaign
format Text
id pubmed-2362261
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23622612009-09-10 Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines Hougaard, S Nørgaard, P Abrahamsen, N Moses, H L Spang-Thomsen, M Skovgaard Poulsen, H Br J Cancer Regular Article Transforming growth factor β (TGF-β) exerts a growth inhibitory effect on many cell types through binding to two types of receptors, the type I and II receptors. Resistance to TGF-β due to lack of type II receptor (RII) has been described in some cancer types including small cell lung cancer (SCLC). The purpose of this study was to examine the cause of absent RII expression in SCLC cell lines. Northern blot analysis showed that RII RNA expression was very weak in 16 of 21 cell lines. To investigate if the absence of RII transcript was due to mutations, we screened the poly-A tract for mutations, but no mutations were detected. Additional screening for mutations of the RII gene revealed a GG to TT base substitution in one cell line, which did not express RII. This mutation generates a stop codon resulting in predicted synthesis of a truncated RII of 219 amino acids. The nature of the mutation, which has not previously been observed in RII, has been linked to exposure to benzo[a]-pyrene, a component of cigarette smoke. Since RII has been mapped to chromosome 3p22 and nearby loci are often hypermethylated in SCLC, it was examined whether the lack of RII expression was due to hypermethylation. Southern blot analysis of the RII promoter did not show altered methylation patterns. The restriction endonuclease pattern of the RII gene was altered in two SCLC cell lines when digested with Sma 1. However, treatment with 5-aza-2′-deoxycytidine did not induce expression of RII mRNA. Our results indicate that in SCLC lack of RII mRNA is not commonly due to mutations and inactivation of RII transcription was not due to hypermethylation of the RII promoter or gene. Thus, these data show that in most cases of the SCLC cell lines, the RII gene and promoter is intact in spite of absent RII expression. However, the nature of the mutation found could suggest that it was caused by cigarette smoking. © 1999 Cancer Research Campaign Nature Publishing Group 1999-03 /pmc/articles/PMC2362261/ /pubmed/10098728 http://dx.doi.org/10.1038/sj.bjc.6690161 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Hougaard, S
Nørgaard, P
Abrahamsen, N
Moses, H L
Spang-Thomsen, M
Skovgaard Poulsen, H
Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
title Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
title_full Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
title_fullStr Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
title_full_unstemmed Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
title_short Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
title_sort inactivation of the transforming growth factor β type ii receptor in human small cell lung cancer cell lines
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362261/
https://www.ncbi.nlm.nih.gov/pubmed/10098728
http://dx.doi.org/10.1038/sj.bjc.6690161
work_keys_str_mv AT hougaards inactivationofthetransforminggrowthfactorbtypeiireceptorinhumansmallcelllungcancercelllines
AT nørgaardp inactivationofthetransforminggrowthfactorbtypeiireceptorinhumansmallcelllungcancercelllines
AT abrahamsenn inactivationofthetransforminggrowthfactorbtypeiireceptorinhumansmallcelllungcancercelllines
AT moseshl inactivationofthetransforminggrowthfactorbtypeiireceptorinhumansmallcelllungcancercelllines
AT spangthomsenm inactivationofthetransforminggrowthfactorbtypeiireceptorinhumansmallcelllungcancercelllines
AT skovgaardpoulsenh inactivationofthetransforminggrowthfactorbtypeiireceptorinhumansmallcelllungcancercelllines